Materias dentro de su búsqueda.
Mostrando 16,581 - 16,600 Resultados de 16,624 Para Buscar '"hepatitis B"', tiempo de consulta: 0.38s Limitar resultados
  1. 16581
    “…We enrolled children aged 5–17 months without serious acute or chronic illness who had previously received three doses of diphtheria, tetanus, pertussis, and hepatitis B vaccine and at least three doses of oral polio vaccine. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of RTS,S/AS01(E) malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial
  2. 16582
    “…Alcoholic liver disease was the most common risk predictive factor seen in 30% of patients. Hepatitis B and C-associated with CLD was seen in 20%. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P406 Rise in HIV negative Cryptococcal infection in liver disease patient: epidemiology, risk factor, antifungal susceptibility profile from tertiary care hepatobiliary center
  3. 16583
    “…Real-time PCR was used for detecting 20 different viral agents other than EVs (six herpesviruses, human polyomavirus [BK virus and JC virus], parvovirus B19, hepatitis B virus, hepatitis C virus, hepatitis A virus, mumps, rubella, influenza A/B, parainfluenza 1–4, respiratory syncytial virus, astrovirus, norovirus, rotavirus). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study
  4. 16584
    “…The study included HIV-negative PN ≥ 18 years with first dispense of daily oral PrEP (≥30-day supply) between 10/19-5/21 followed for ≥6 mo; individuals with hepatitis B or post-exposure prophylaxis were excluded. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2087. Prescription Adherence and Persistence on Oral Pre-exposure Prophylaxis (PrEP) Among PrEP-Naive (PN) Individuals After F/TAF Approval in the United States (US)
  5. 16585
    por Alexiev, Ivailo, Dimitrova, Reneta, Gancheva, Anna, Kostadinova, Asya, Stoycheva, Mariyana, Nikolova, Daniela, Elenkov, Ivaylo, Tilișcan, Cătălin, Predescu, Mioara, Păunescu, Bogdan, Streinu-Cercel, Anca, Săndulescu, Oana, Șchiopu, Claudiu Mihai, Hristache, Mădălina, Brîndușe, Lăcrămioara Aurelia, Streinu-Cercel, Adrian, Todorovic, Marija, Siljic, Marina, Salemovic, Dubravka, Nikolic, Valentina, Pesic-Pavlovic, Ivana, Ranin, Jovan, Jevtovic, Djordje, Stanojevic, Maja, Tudor, Ana Maria, Vlad, Delia, Mărdărescu, Mariana, Petrea, Sorin, Petre, Cristina, Neagu-Drăghicenoiu, Ruxandra, Ungurianu, Rodica, Cibea, Alina, Chirilă, Odette, Anghelina, Cristian, Coserea, Ileana, Krikelli, Pantelia-Amalia, Pavlitina, Eirini, Psichogiou, Mina, Lamnisos, Demetris, Williams, Leslie, Korobchuk, Anya, Skaathun, Britt, Smyrnov, Pavlo, Schneider, John, Sypsa, Vana, Paraskevis, Dimitrios, Hatzakis, Angelos, Friedman, Samuel R., Nikolopoulos, Georgios K., Dragović, Gordana, Srdić, Danica, Khawla, Al Musalhi, Soldatović, Ivan, Nikolić, Jelena, Jevtović, Djordje, Nair, Devaki, Temereanca, Aura, Rosca, Adelina, Ene, Luminita, Soontornniyomkij, Benchawa, Diaconu, Carmen, Dita, Claudia, Achim, Cristian, Ruta, Simona, Benea, Șerban, Moroti, Ruxandra, Jipa, Raluca, Manea, Eliza, Stan, Andrada, Benea, Elisabeta, Oțelea, Dan, Hristea, Adriana, Hristea, Adriana, Lăpădat, Irina, Jipa, Raluca, Moroti, Ruxandra, Benea, Șerban, Antonică, Doina, Panait, Irina, Petre, Roxana, Kowalska, Justyna D., Pietraszkiewicz, Ewa, Grycner, Ewa, Firlag-Burkacka, Ewa, Horban, Andrzej, Vlaicu, Ovidiu, Bănică, Leontina, Paraschiv, Simona, Tudor, Ana-Maria, Moroti, Ruxandra, Oțelea, Dan, Dimitrijević, Bojana, Soldatović, Ivan, Jevtović, Đorđe, Kusić, Jovana, Salemović, Dubravka, Ranin, Jovan, Dragović, Gordana, Florea, Dragoș, Bădicuț, Ioana, Rafila, Alexandru, Camburu, Cornel, Histrea, Adriana, Frățilă, Mihaela, Oțelea, Dan, Gmizic, Ivana, Salemovic, Dubravka, Pesic-Pavlovic, Ivana, Siljic, Marina, Nikolic, Valentina, Djonin-Nenezic, Miljana, Milosevic, Ivana, Brmbolic, Branko, Stanojevic, Maja, Streinu-Cercel, Anca, Săndulescu, Oana, Neguț, Alina Cristina, Predescu, Mioara, Mărdărescu, Alexandra, Săndulescu, Mihai, Streinu-Cercel, Adrian, Pérez, Ana Belen, Chueca, Natalia, Álvarez, Marta, Alados, Juan Carlos, Rivero, Antonio, Vera, Francisco, Delgado, Marcial, Salmeron, Javier, Jiménez, Miguel, Blanco, Maria José, Diago, Moises, Garcia-deltoro, Miguel, Alvarez, Marta, Téllez, Francisco, García, Federico, Tănase, Diana, Manea, Eliza, Bacruban, Rodica, Florea, Dragoș, Oțelea, Dan, Rafila, Alexandru, Mărdărescu, Mariana, Hristea, Adriana, Grgic, Ivana, Planinic, Ana, Santak, Maja, Gorenec, Lana, Lepej, Snjezana Zidovec, Vince, Adriana, Manea, Eliza, Hristea, Adriana, Benea, Șerban, Moroti, Ruxandra, Tănase, Diana, Niculae, Cristian M., Merisor, Simona, Jipa, Raluca, Paraskevis, Dimitrios, Kostaki, Evangelia, Nikolopoulos, Georgios K., Sypsa, Vana, Psichogiou, Mina, Paraskeva, Dimitra, Skoutelis, Athanassios, Malliori, Meni, Friedman, Samuel R., Hatzakis, Angelos, Hackiewicz, Malgorzata, Zabek, Piotr, Firlag-Burkacka, Ewa, Horban, Andrzej, Kowalska, Justyna Dominika, Lunar, Maja M., Mlakar, Jana, Poljak, Mario, Bănică, Leontina, Martin, Eliza, Gheorghiță, Valeriu, Petrescu, Andrei, Oțelea, Dan, Popescu, Costin-Ioan, Paraschiv, Simona, Neaga, Emil, Ovidiu, Vlaicu, Juncu, Andrei, Bănică, Leontina, Paraschiv, Simona, Oțelea, Dan, Popescu, Costin-Ioan, Luca, Adrian, Lazăr, Florin, Luca, Anca Elena, Ene, Luminița, Achim, Cristian, Gingăraş, Cosmina, Anton, Ștefan Adrian, Rădoi, Roxana, Tetradov, Simona, Țârdei, Grațiela, Nica, Maria, Capşa, Razvan Alexandru, Achim, Cristian L., Oprea, Cristiana, Ene, Luminița, Szymańska, Bogna, Gawron, Natalia, Pluta, Agnieszka, Łojek, Emilia, Firląg-Burkacka, Ewa, Horban, Andrzej, Bornstein, Robert, Burcoș, Olivia, Erscoiu, Simona Manuela, Cojanu, Filofteia Bănicioiu, Toderan, Andreea, Nica, Maria, Popa, Ionuț Cristian, Ceaușu, Emanoil, Calistru, Petre Iacob, Arbune, Manuela, Alexandrache, Mirela, Arbune, Anca-Adriana, Voinescu, Doina-Carina, Diaconu, Ioan-Alexandru, Stratan, Laurențiu, Aramă, Victoria, Nichita, Luciana, Diaconu, Alexandra, Negru, Anca, Orfanu, Alina, Leuștean, Anca, Ion, Daniela Adriana, Ianache, Irina, Oprea, Cristiana, Leuștean, Anca, Popescu, Cristina, Orfanu, Alina, Negru, Anca, Catana, Remulus, Murariu, Cristina, Diaconu, Ioan-Alexandru, Rădulescu, Mihaela, Tilișcan, Cătălin, Aramă, Victoria, Marincu, Iosif, Poptelecan, Patricia, Bică, Valeria, Lazăr, Florin, Tirnea, Livius, Ianache, Irina, Rădoi, Roxana, Nica, Manuela, Țârdei, Grațiela, Ene, Luminița, Ceaușu, Emanoil, Calistru, Petre, Oprea, Cristiana, Osoianu, Iurie, Halacu, Ala, Stoian, Andreea Cristina, Dumitrescu, Florentina, Diaconescu, Iulian, Cupșa, Augustin, Giubelan, Lucian, Ionescu, Loredana, Niculescu, Irina, Chiriac, Carmen, Șincu, Nina, Kezdi, Iringo Zaharia, Georgescu, Anca, Țilea, Brândușa, Girbovan, Cristina, Incze, Andrea, Fodor, Andrea, Cibea, Alina, Mărdărescu, Mariana, Petre, Cristina, Drăghicenoiu, Ruxandra, Ungurianu, Rodica, Tudor, Ana Maria, Vlad, Delia, Matei, Carina, Dumea, Elena, Petcu, Lucian Cristian, Cambrea, Simona Claudia, Dumitrescu, Florentina, Cupsa, Augustin, Stoian, Andreea Cristina, Giubelan, Lucian, Niculescu, Irina, Diaconescu, Iulian, Hurezeanu, Dan, Dragonu, Livia, Cotulbea, Mioara, Erscoiu, Simona Manuela, Popa, Ionuț Cristian, Stroie, Denisa, Ionescu, Petronela, Duță, Nedeea, Dobrea, Camelia, Voican, Irina, Ceaușu, Emanoil, Calistru, Petre Iacob, Lazăr, Florin, Giubelan, Lucian, Cupșa, Augustin, Diaconescu, Iulian, Dumitrescu, Florentina, Hurezeanu, Dan, Dragonu, Livia, Niculescu, Irina, Stoian, Andreea Cristina, Obretin, Oana, Stănescu, Mariana, Jianu, Mihai, Gorenec, Lana, Lepej, Snjezana Zidovec, Grgic, Ivana, Planinic, Ana, Bes, Janja Iscic, Vince, Adriana, Begovac, Josip, Horga, Luminița Elena, Itu, Corina, Horga, Luminița Elena, David-Aldea, Laura Augusta, Ciorogar, Anca, Jianu, Cristian, Lupșe, Mihaela, Caramangiu, Iuliana, Roșca, Ovidiu, Cialma, Monica, Ardeleanu, Andreea, Marincu, Iosif, Jipa, Raluca, Manea, Eliza, Benea, Șerban, Lăpădat, Irina, Irimescu, Nicoleta, Panait, Irina, Niculae, Cristian, Hristea, Adriana, Kusic, Jovana, Jevtovic, Djordje, Salemovic, Dubravka, Ranin, Jovan, Dimitrijevic, Bozana, Dragovic, Gordana, Aldea-David, Laura-Augusta, Manciuc, Carmen, Nicolau, Cristina, Prisăcariu, Liviu, Largu, Alexandra, Mărdărescu, Mariana, Streinu-Cercel, Adrian, Petre, Cristina, Iancu, Marieta, Vintilă, Sanda, Vitelaru, Daniela, Ionel, Iosif, Șchiopu, Claudiu Mihai, Mărdărescu, Alexandra-Henriette, Micsanschi, Pavel, Holban, Tiberiu, Bîstrițchi, Ina, Pârțână, Lucia, Nagîț, Angela, Popovici, Svetlana, Talmaci, Maria, Cucerova, Irina, Mitrescu, Sorina Georgiana, Mihalcea, Dana, Caramangiu, Iulia, Roșca, Ovidiu, Maricu, Iosif, Negru, Anca, Munteanu, Daniela, Aramă, Victoria, Mihăilescu, Raluca, Diaconu, Ioan, Catana, Remulus, Popescu, Cristina, Orfanu, Alina, Leuștean, Anca, Rădulescu, Mihaela, Tilișcan, Cătălin, Năstase, Raluca, Molagic, Violeta, Duport, Irina, Dragomirescu, Cristina, Aramă, Ștefan Sorin, Negruț, Nicoleta M., Niță, Violeta Elena, Munteanu, Daniela Ioana, Mihăilescu, Raluca, Diaconu, Ioan, Negru, Anca, Popescu, Cristina, Aramă, Victoria, Orfanu, Alina, Popescu, Cristina, Leuștean, Anca, Negru, Anca, Catana, Remulus, Diaconu, Ioan, Tilișcan, Cătălin, Aramă, Victoria, Aramă, Sorin Ștefan, Pavlovia, Ivana Pesic, Salemovic, Dubravka, Ranin, Jovan, Jevtovic, Djordje, Roșca, Ovidiu, Ardeleanu, Andreea, Caramangiu, Iulia, Desaga, Daniela, Bică, Valerica, Mitrescu, Sorina, Marincu, Iosif, Siljic, Marina, Salemovic, Dubravka, Nikolic, Valentina, Jevtovic, Djordje, Pesic-Pavlovic, Ivana, Ranin, Jovan, Todorovic, Marija, Stanojevic, Maja, Șincu, Nina-Ioana, Georgescu, Anca, Țilea, Brândușa, Kezdi, Iringo Zaharia, Incze, Andrea, Gârbovan, Cristina, Chiriac, Carmen Lucia, Luca, Anca Elena, Lazăr, Florin, Luca, Adrian, Ene, Luminița, Rădoi, Roxana, Talnariu, Adina, Suciu, Silvia, Achim, Cristian, Iacob, Diana Gabriela, Florea, Dragoș, Iacob, Simona, Arbune, Manuela, Drăgănescu, Miruna, Iancu, Alina, Moroti, Ruxandra, Niculae, Cristian M., Merisor, Simona, Manea, Eliza, Benea, Serban, Stan, Andrada, Hrisca, Raluca, Jipa, Raluca, Tanase, Diana, Hristea, Adriana, Grgic, Ivana, Planinic, Ana, Gorenec, Lana, Lepej, Snjezana Zidovec, Vince, Adriana
    Publicado 2016
    “…O1 HIV-1 diversity in Bulgaria (current molecular epidemiological picture) Ivailo Alexiev, Reneta Dimitrova, Anna Gancheva, Asya Kostadinova, Mariyana Stoycheva, Daniela Nikolova, Ivaylo Elenkov O2 Knowledge, attitudes and practices of the general population on HIV/AIDS, hepatitis B and C in Romania Cătălin Tilișcan, Mioara Predescu, Bogdan Păunescu, Anca Streinu-Cercel, Oana Săndulescu, Claudiu Mihai Șchiopu, Mădălina Hristache, Lăcrămioara Aurelia Brîndușe, Adrian Streinu-Cercel O3 The prevalence of human leukocyte antigen-B*57:01 allele carriers and CXCR4 tropism among newly diagnosed HIV infected patients in Serbia Marija Todorovic, Marina Siljic, Dubravka Salemovic, Valentina Nikolic, Ivana Pesic-Pavlovic, Jovan Ranin, Djordje Jevtovic, Maja Stanojevic O4 HIV transmission among stable serodiscordant couples from the former Pediatric Cohort follow up in the National Institute of Infectious Diseases Ana Maria Tudor, Delia Vlad, Mariana Mărdărescu, Sorin Petrea, Cristina Petre, Ruxandra Neagu-Drăghicenoiu, Rodica Ungurianu, Alina Cibea, Odette Chirilă, Cristian Anghelina, Ileana Coserea O5 Unemployment is associated with syringe sharing among people who inject drugs in Greece Pantelia-Amalia Krikelli, Eirini Pavlitina, Mina Psichogiou, Demetris Lamnisos, Leslie Williams, Anya Korobchuk, Britt Skaathun, Pavlo Smyrnov, John Schneider, Vana Sypsa, Dimitrios Paraskevis, Angelos Hatzakis, Samuel R. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Proceedings of The 8th Romanian National HIV/AIDS Congress and The 3rd Central European HIV Forum: Sibiu, Romania. 5-7 May 2016
  6. 16586
    “…The guidelines included recommendations for safety monitoring prior to BRM therapy, such as the tuberculosis (TB) test, Hepatitis B surface Antigen (HBsAg) test, liver function test (LFT), complete blood count (CBC), up-to-date vaccinations, risk assessment for cancer, pregnancy testing, monitoring for contraindications with concomitant medications, concomitant disease state risk assessment, and patient education. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improvement in Safety Monitoring of Biologic Response Modifiers After the Implementation of Clinical Care Guidelines by a Specialty Pharmacy Service in an Academic Health System
  7. 16587
    “…RESULTS: Twenty-nine studies from Somalia and Somali immigrants (United Kingdom, United States, Italy, Libya) with a combined sample size for each type of viral hepatitis [hepatitis A virus (HAV): 1564, hepatitis B virus (HBV): 8756, hepatitis C virus (HCV): 6257, hepatitis D virus (HDV): 375 and hepatitis E virus (HEV): 278] were analyzed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study
  8. 16588
    “…Randomization was stratified by screening HIV-1 RNA (≤/>100,000 copies/mL) and hepatitis B/C co-infection (yes/no). The efficacy endpoint of interest at week 96 was HIV-1 RNA <50 copies/mL with predefined noninferiority margin of 10%. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB1. Doravirine/Lamivudine/Tenofovir DF Continues to Be NonInferior to Efavirenz/Emtricitabine/Tenofovir DF in Treatment-Naïve Adults With HIV-1 Infection: Week 96 Results of the DRIVE-AHEAD Trial
  9. 16589
    “…Two hundred and three patients had chronic hepatitis B, 183 chronic hepatitis C, 198 alcoholic liver disease, 28 autoimmune cholestatic liver diseases, 15 autoimmune hepatitis, and 5 with other liver-related disorders. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
  10. 16590
    “…Faecal calprotectin was normal. EBV, CMV, Hepatitis B and C and HIV were negative. Repeat immunology confirmed a type II cryoglobulinemia of 0.95 and C4 of 0.01. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    EP36 Caecal vasculitis: a rare and dangerous complication of Sjögren’s syndrome
  11. 16591
    “…The protective effects of YCHD against OJ were closely related to 20 pathways, including the hepatitis-B, the mitogen-activated protein kinase, the phosphatidylinositol 3-kinase/protein kinase B, and tumor necrosis factor signaling pathways. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The mechanism of Yinchenhao decoction in treating obstructive-jaundice-induced liver injury based on Nrf2 signaling pathway
  12. 16592
    “…The multivariate analyses showed that HH without cirrhosis (aOR, 28.8; 95%CI, 10.4–80.1; P < 0.0001), biliary cirrhosis (aOR, 19.3; 95%CI, 13.4–27.6; P < 0.0001), non-alcoholic cirrhosis (aOR, 17.4; 95%CI, 16.5–18.4; P < 0.0001), alcoholic cirrhosis (aOR, 16.9; 95%CI, 15.9–17.9; P < 0.0001), hepatitis B (aOR, 12.1; 95%CI, 10.85–13.60; P < 0.0001), hepatitis C (aOR, 8.58; 95%CI, 8.20–8.98; P < 0.0001), Wilson disease (aOR, 4.27; 95%CI, 1.18–15.41; P < 0.0001), NAFLD or NASH (aOR, 2.96; 95%CI, 2.73–3.20; P < 0.0001), alpha1-antitrypsin deficiency (aOR, 2.10; 95%CI, 1.21–3.64; P < 0.0001), diabetes mellitus without chronic complications (aOR, 1.17; 95%CI, 1.13–1.21; P < 0.0001), and blood transfusion (aOR, 1.80; 95%CI, 1.69–1.92; P < 0.0001) are independent risk factor for liver cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study
  13. 16593
    “…After the formulation of nine key questions for six viruses (hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papilloma virus, human T-lymphotropic virus I/II and Zika virus) by a group of experts, literature searches and assessments were performed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ESHRE guideline: medically assisted reproduction in patients with a viral infection/disease
  14. 16594
    “…His QuantiFERON, HIV and syphilis serology were negative; however, his hepatitis B core antibody was positive with a negative DNA. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    P15 JAKi of all trades
  15. 16595
    “…Infectious screen revealed negative blood cultures, HIV, Hepatitis B and C, EBV, CMV and Treponema pallidum serology. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    O04 Large vessel vasculitis related to COVID-19 infection
  16. 16596
    “…It has been proposed that patients with hematologic malignancy and autoimmune diseases receiving anti-CD20 monoclonal antibody (mAb) therapy are particularly at risk of severe Coronavirus disease (COVID-19) because the profound and long-lasting B-cell depletion induced by anti-CD20 mAb may impair virus clearance and may also contribute to reactivation of latent viruses, especially hepatitis B and JC viruses. As of July 20, 2020, the total number of COVID-19 cases reported by the Italian authorities reached 245,000. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies
  17. 16597
    “…Exclusion criteria included (but were not limited to) travel overseas within 14 days of screening, intention to travel overseas within 6 months of the screening visit, and the absence of prespecified medical conditions, including immunosuppressive illness, a history of autoimmune disease, malignancy with risk to recur, a bleeding disorder, uncontrolled HIV infection, uncontrolled hepatitis B and C virus infections, SARS-CoV-1 or SARS-CoV-2 infections, an allergy to any vaccine, or a serious medical condition that could interfere with the study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
  18. 16598
    “…BACKGROUND: The primary analysis of the STAT study demonstrated the feasibility, efficacy, and safety of using DTG/3TC as a first-line regimen in a test-and-treat setting through 24 weeks, with therapy adjustments for baseline resistance or hepatitis B virus (HBV) co-infection. Here we present secondary analyses through Week 48 of virologic outcomes in participants by baseline viral load (VL). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    75. High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study
  19. 16599
    “…The study was conducted in Lao People’s Democratic Republic and assessed the effect of using mobile devices for birth notification on outcomes related to coverage and timeliness of Hepatitis B vaccination. However, we are uncertain of the effect of this approach on these outcomes because the certainty of this evidence was assessed as very low. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Birth and death notification via mobile devices: a mixed methods systematic review
  20. 16600
    “…Exclusion criteria: the need for intubation; allergy, intolerance, or contraindication to any study drug including dexamethasone, IV-IG, and interferon-beta; pregnancy or lactation; known HIV positive or active hepatitis B or C. The study will be conducted in several hospitals of the Golestan province, Iran. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial
Herramientas de búsqueda: RSS